DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ advanced 2.55% to $580.41 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.08% to 44,946.12 and the S&P 500 Index falling 0.29% to 6,449.80.
This was the stock's fourth consecutive day of gains.
Regeneron Pharmaceuticals Inc. closed 52.08% short of its 52-week high of $1,211.20, which the company achieved on August 27th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 2.13% to $296.47, Moderna Inc. (MRNA) rose 4.98% to $28.02, and Gilead Sciences Inc. (GILD) fell 0.55% to $118.37.
Trading volume (1.1 M) eclipsed its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 15, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 15, 2025 16:46 ET (20:46 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.